Sign in
Taking people in United StatesNo phase

Home exercise for chemo-brain after cancer with or without type 2 diabetes

Tests home exercise in cancer survivors with chemo-brain, some with diabetes.

Key facts

Who runs it
University of Oklahoma
Where
Oklahoma City, United StatesSee the site
Trial code
Registry title
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
Status
Recruiting
People taking part
38 people, planned
Started
10 Mar 2025
Expected to end
Feb 2027
Type of study
Interventional
Treatments tested
  • Social Cognitive Theory-based, Technology-delivered Physical Activity Program
Record updated
1 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who had chemotherapy for a cancer outside the brain and spine in the last 3 years and report thinking problems since. People with and without type 2 diabetes can join.

Age
18 years or older
Sex
All sexes
Disease stage
Cancer outside the central nervous system, treated within the last three years, including chemotherapy. Some people have type 2 diabetes and some do not.
Earlier treatment
Must have had chemotherapy within the last three years. Must not already be doing 75 or more minutes a week of vigorous exercise, or 150 or more minutes a week of moderate exercise, over the last 3 months.
Biomarker or test result
Type 2 diabetes group: fasted blood glucose of 126 mg/dL (7 mmol/L) or more, 2-hour oral glucose tolerance test of 200 mg/dL (11.1 mmol/L) or more, HbA1c of 6.5% (48 mmol/mol) or more, or taking medicine for high blood sugar. Group without diabetes: fasted blood glucose below 100 mg/dL (5.6 mmol/L), 2-hour oral glucose tolerance test below 140 mg/dL (7.8 mmol/L), or HbA1c below 5.7% (39 mmol/mol).

Main reasons for not taking part

  • Physical activity questionnaire (2017 PAR-Q) shows exercise may be unsafe, unless you have a signed doctor's note
  • Already doing 75 or more minutes a week of vigorous exercise or 150 or more minutes a week of moderate exercise
  • Currently a prisoner
  • Pregnant or planning to become pregnant during the study
  • No smartphone or computer with internet access

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • ≥18 years old
  • ability to speak/read English
  • ability to provide informed consent
  • underwent treatment within the last three years for a non-central nervous system-related cancer with said treatment having included chemotherapy
  • self-reported cognitive difficulties following cancer treatment
  • For CS+T2D: current T2D diagnosis as classified by a fasted blood glucose of ≥126 mg/dL, 2-hour oral glucose tolerance test of ≥200 mg/dL, HbA1c level of ≥6.5%, or use of medications to treat hyperglycemia (e.g., Metformin) or For CS: no current T2D diagnosis as classified by a fasted blood glucose <100 mg/dL, 2-hour oral glucose tolerance test <140 mg/dL, or HbA1c level of <5.7%. Presence/absence of T2D to be confirmed preferentially via physician's documentation
  • own smartphone and/or computer with internet access
  • willing to participate in the 12-week remotely-delivered PA program

Who cannot take part

  • reporting a Physical Activity Readiness Questionnaire (2017 PAR-Q) score that indicates PA may potentially be unsafe, unless the participant produces a signed doctor's note. We will define 2017 PAR-Q+ scores as indicating that PA may potentially be unsafe as responding "Yes" to any of the follow-up questions except [1] if the individual indicates that they have high blood pressure but subsequent responses indicate that they do not have problems keeping it under control and that their resting blood pressure is less than 160/90 mmHg, and [2] if the individual indicates that they have a metabolic condition but subsequent responses indicate that they do not have problems controlling their blood sugar levels, do not any experience signs or symptoms of hypoglycemia, and do not have any signs of symptoms of listed diabetes complications)
  • engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months
  • currently a prisoner, pregnant, or planning to become pregnant during study

Where in United States

  • University of Oklahoma Health SciencesOklahoma City, United StatesContact: Zachary C Pope, PhDTaking people

About the trial

What the trial wants to find out

The growing U.S. cancer survivor population is projected to hit 26M by 2040. Chemotherapy represents an effective cancer treatment but can diminish cancer survivors' quality of life-particularly cognitive function-through select pathophysiological processes. Research on chemotherapy-induced cognitive impairment (hereafter, 'chemo-brain') is therefore critical. Chemotherapy disrupts immune system function and antioxidant regulation, causing inflammatory molecule release and damaging the brain's blood vessels. The brain's vascular function and, possibly, its neurons, are subsequently impaired-likely contributing to chemo-brain. Type 2 diabetes (T2D), a common cancer survivor comorbidity, shares underlying pathophysiology with chemo-brain. T2D-related insulin resistance can precipitate repeated high blood sugar episodes which increase inflammatory molecule release. In individuals with T2D without cancer, negative relationships are observed between inflammatory molecule concentrations and the brain's vascular and/or cognitive function. Cancer survivors with T2D might thus have higher chemo-brain risk than those without T2D. Yet, more research must compare how the brain's vascular function, as well as cognitive, inflammatory, and cardiometabolic indices, differ between these groups. Physical activity (PA) counteracts chemo-brain's and T2D's pathophysiology, with higher PA/fitness resulting in better vascular function of the brain, lower inflammatory molecule concentrations, and improved insulin sensitivity. We are therefore conducting a 30-participant quasi-experimental pilot study in cancer survivors with (cases) and without (controls) T2D. We will first investigate between-group differences in the brain's vascular function as well as cognitive, inflammatory, cardiometabolic, and epigenetic outcomes. We will then examine between-group changes in these outcomes and select psychosocial metrics during a 12-week technology-based PA program-potentially further elucidating involved mechanisms.

The group in the trial

  • Social Cognitive Theory-based, Technology-delivered Physical Activity ProgramTreatment being tested

    Participants will engage in a 12-week program of aerobic and muscle-strengthening physical activity. This program will be delivered remotely via two smartphone applications--one for providing health education, goal setting, and journaling features and the other for delivery of the physical activity program in a highly-personalized and HIPAA-compliant manner. Participants will receive a Fitbit to track their activity and resistance bands to use during their resistance training physical activity. All program components will be based in the Social Cognitive Theory and will target improving participants' physiological and psychological health outcomes.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cerebrovascular, Cognitive, Pro-Inflammatory, and Cardiometabolic Outcomes in Cancer Survivors With and Without Type II Diabetes Reporting Chemo-Brain: Baseline Differences and Impact of Activity
Plain-language title
Home exercise for chemo-brain after cancer with or without type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
1 May 2026